Skip to main content
PMC home page
Thorax logoLink to Thorax
. 1999 Aug;54(Suppl 2):S58–S62. doi: 10.1136/thx.54.2008.s58

The anti-inflammatory effects of macrolides

D Wales, M Woodhead
PMCID: PMC1765933  PMID: 10451695

Full Text

The Full Text of this article is available as a PDF (116.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agen C., Danesi R., Blandizzi C., Costa M., Stacchini B., Favini P., Del Tacca M. Macrolide antibiotics as antiinflammatory agents: roxithromycin in an unexpected role. Agents Actions. 1993 Jan;38(1-2):85–90. doi: 10.1007/BF02027218. [DOI] [PubMed] [Google Scholar]
  2. Anderson R. Erythromycin and roxithromycin potentiate human neutrophil locomotion in vitro by inhibition of leukoattractant-activated superoxide generation and autooxidation. J Infect Dis. 1989 May;159(5):966–973. doi: 10.1093/infdis/159.5.966. [DOI] [PubMed] [Google Scholar]
  3. Anderson R., Fernandes A. C., Eftychis H. E. Studies on the effects of ingestion of a single 500 mg oral dose of erythromycin stearate on leucocyte motility and transformation and on release in vitro of prostaglandin E2 by stimulated leucocytes. J Antimicrob Chemother. 1984 Jul;14(1):41–50. doi: 10.1093/jac/14.1.41. [DOI] [PubMed] [Google Scholar]
  4. Ashitani J., Mukae H., Nakazato M., Ihi T., Mashimoto H., Kadota J., Kohno S., Matsukura S. Elevated concentrations of defensins in bronchoalveolar lavage fluid in diffuse panbronchiolitis. Eur Respir J. 1998 Jan;11(1):104–111. doi: 10.1183/09031936.98.11010104. [DOI] [PubMed] [Google Scholar]
  5. Blasi F., Cosentini R., Raccanelli R., Massari F. M., Arosio C., Tarsia P., Allegra L. A possible association of Chlamydia pneumoniae infection and acute myocardial infarction in patients younger than 65 years of age. Chest. 1997 Aug;112(2):309–312. doi: 10.1378/chest.112.2.309. [DOI] [PubMed] [Google Scholar]
  6. Campbell L. A., O'Brien E. R., Cappuccio A. L., Kuo C. C., Wang S. P., Stewart D., Patton D. L., Cummings P. K., Grayston J. T. Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues. J Infect Dis. 1995 Aug;172(2):585–588. doi: 10.1093/infdis/172.2.585. [DOI] [PubMed] [Google Scholar]
  7. Finsnes F., Skjønsberg O. H., Tønnessen T., Naess O., Lyberg T., Christensen G. Endothelin production and effects of endothelin antagonism during experimental airway inflammation. Am J Respir Crit Care Med. 1997 Apr;155(4):1404–1412. doi: 10.1164/ajrccm.155.4.9105086. [DOI] [PubMed] [Google Scholar]
  8. Gupta S., Leatham E. W., Carrington D., Mendall M. A., Kaski J. C., Camm A. J. Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction. Circulation. 1997 Jul 15;96(2):404–407. doi: 10.1161/01.cir.96.2.404. [DOI] [PubMed] [Google Scholar]
  9. Gurfinkel E., Bozovich G., Daroca A., Beck E., Mautner B. Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS Pilot Study. ROXIS Study Group. Lancet. 1997 Aug 9;350(9075):404–407. doi: 10.1016/s0140-6736(97)07201-2. [DOI] [PubMed] [Google Scholar]
  10. Hand W. L., Hand D. L., King-Thompson N. L. Antibiotic inhibition of the respiratory burst response in human polymorphonuclear leukocytes. Antimicrob Agents Chemother. 1990 May;34(5):863–870. doi: 10.1128/aac.34.5.863. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Howe R. A., Spencer R. C. Macrolides for the treatment of Pseudomonas aeruginosa infections? J Antimicrob Chemother. 1997 Aug;40(2):153–155. doi: 10.1093/jac/40.2.153. [DOI] [PubMed] [Google Scholar]
  12. Jaffé A., Francis J., Rosenthal M., Bush A. Long-term azithromycin may improve lung function in children with cystic fibrosis. Lancet. 1998 Feb 7;351(9100):420–420. doi: 10.1016/S0140-6736(05)78360-4. [DOI] [PubMed] [Google Scholar]
  13. Kadota J., Sakito O., Kohno S., Sawa H., Mukae H., Oda H., Kawakami K., Fukushima K., Hiratani K., Hara K. A mechanism of erythromycin treatment in patients with diffuse panbronchiolitis. Am Rev Respir Dis. 1993 Jan;147(1):153–159. doi: 10.1164/ajrccm/147.1.153. [DOI] [PubMed] [Google Scholar]
  14. Kawasaki S., Takizawa H., Ohtoshi T., Takeuchi N., Kohyama T., Nakamura H., Kasama T., Kobayashi K., Nakahara K., Morita Y. Roxithromycin inhibits cytokine production by and neutrophil attachment to human bronchial epithelial cells in vitro. Antimicrob Agents Chemother. 1998 Jun;42(6):1499–1502. doi: 10.1128/aac.42.6.1499. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Khair O. A., Devalia J. L., Abdelaziz M. M., Sapsford R. J., Davies R. J. Effect of erythromycin on Haemophilus influenzae endotoxin-induced release of IL-6, IL-8 and sICAM-1 by cultured human bronchial epithelial cells. Eur Respir J. 1995 Sep;8(9):1451–1457. [PubMed] [Google Scholar]
  16. Kobayashi H. Biofilm disease: its clinical manifestation and therapeutic possibilities of macrolides. Am J Med. 1995 Dec 29;99(6A):26S–30S. doi: 10.1016/s0002-9343(99)80282-4. [DOI] [PubMed] [Google Scholar]
  17. Koh Y. Y., Lee M. H., Sun Y. H., Sung K. W., Chae J. H. Effect of roxithromycin on airway responsiveness in children with bronchiectasis: a double-blind, placebo-controlled study. Eur Respir J. 1997 May;10(5):994–999. doi: 10.1183/09031936.97.10050994. [DOI] [PubMed] [Google Scholar]
  18. Labro M. T., el Benna J., Babin-Chevaye C. Comparison of the in-vitro effect of several macrolides on the oxidative burst of human neutrophils. J Antimicrob Chemother. 1989 Oct;24(4):561–572. doi: 10.1093/jac/24.4.561. [DOI] [PubMed] [Google Scholar]
  19. Miyatake H., Taki F., Taniguchi H., Suzuki R., Takagi K., Satake T. Erythromycin reduces the severity of bronchial hyperresponsiveness in asthma. Chest. 1991 Mar;99(3):670–673. doi: 10.1378/chest.99.3.670. [DOI] [PubMed] [Google Scholar]
  20. Miyatake H., Taki F., Taniguchi H., Suzuki R., Takagi K., Satake T. Erythromycin reduces the severity of bronchial hyperresponsiveness in asthma. Chest. 1991 Mar;99(3):670–673. doi: 10.1378/chest.99.3.670. [DOI] [PubMed] [Google Scholar]
  21. Mukae H., Kadota J., Ashitani J., Taniguchi H., Mashimoto H., Kohno S., Matsukura S. Elevated levels of soluble adhesion molecules in serum of patients with diffuse panbronchiolitis. Chest. 1997 Dec;112(6):1615–1621. doi: 10.1378/chest.112.6.1615. [DOI] [PubMed] [Google Scholar]
  22. Nelson S., Summer W. R., Terry P. B., Warr G. A., Jakab G. J. Erythromycin-induced suppression of pulmonary antibacterial defenses. A potential mechanism of superinfection in the lung. Am Rev Respir Dis. 1987 Nov;136(5):1207–1212. doi: 10.1164/ajrccm/136.5.1207. [DOI] [PubMed] [Google Scholar]
  23. Rosenberg S. M., Gerhard H., Grunstein M. M., Schramm C. M. Use of TAO without methylprednisolone in the treatment of severe asthma. Chest. 1991 Sep;100(3):849–850. doi: 10.1378/chest.100.3.849. [DOI] [PubMed] [Google Scholar]
  24. Schultz M. J., Speelman P., Zaat S., van Deventer S. J., van der Poll T. Erythromycin inhibits tumor necrosis factor alpha and interleukin 6 production induced by heat-killed Streptococcus pneumoniae in whole blood. Antimicrob Agents Chemother. 1998 Jul;42(7):1605–1609. doi: 10.1128/aac.42.7.1605. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Shimizu T., Kato M., Mochizuki H., Tokuyama K., Morikawa A., Kuroume T. Roxithromycin reduces the degree of bronchial hyperresponsiveness in children with asthma. Chest. 1994 Aug;106(2):458–461. doi: 10.1378/chest.106.2.458. [DOI] [PubMed] [Google Scholar]
  26. Shirai T., Sato A., Chida K. Effect of 14-membered ring macrolide therapy on chronic respiratory tract infections and polymorphonuclear leukocyte activity. Intern Med. 1995 Jun;34(6):469–474. doi: 10.2169/internalmedicine.34.469. [DOI] [PubMed] [Google Scholar]
  27. Takizawa H., Desaki M., Ohtoshi T., Kawasaki S., Kohyama T., Sato M., Nakajima J., Yanagisawa M., Ito K. Erythromycin and clarithromycin attenuate cytokine-induced endothelin-1 expression in human bronchial epithelial cells. Eur Respir J. 1998 Jul;12(1):57–63. doi: 10.1183/09031936.98.12010057. [DOI] [PubMed] [Google Scholar]
  28. Tamaoki J., Tagaya E., Sakai A., Konno K. Effects of macrolide antibiotics on neurally mediated contraction of human isolated bronchus. J Allergy Clin Immunol. 1995 Apr;95(4):853–859. doi: 10.1016/s0091-6749(95)70129-x. [DOI] [PubMed] [Google Scholar]
  29. Tsang K. W., Ho P. I., Chan K. N., Ip M. S., Lam W. K., Ho C. S., Yuen K. Y., Ooi G. C., Amitani R., Tanaka E. A pilot study of low-dose erythromycin in bronchiectasis. Eur Respir J. 1999 Feb;13(2):361–364. doi: 10.1183/09031936.99.13236199. [DOI] [PubMed] [Google Scholar]
  30. Vittori E., Marini M., Fasoli A., De Franchis R., Mattoli S. Increased expression of endothelin in bronchial epithelial cells of asthmatic patients and effect of corticosteroids. Am Rev Respir Dis. 1992 Nov;146(5 Pt 1):1320–1325. doi: 10.1164/ajrccm/146.5_Pt_1.1320. [DOI] [PubMed] [Google Scholar]
  31. Witzel D. A., Johnson J. H., Younger R. L. Partial lobectomy of bovine liver: a new biopsy technique. Cornell Vet. 1975 Jan;65(1):112–119. [PubMed] [Google Scholar]
  32. Yamamoto M., Kondo A., Tamura M., Izumi T., Ina Y., Noda M. [Long-term therapeutic effects of erythromycin and newquinolone antibacterial agents on diffuse panbronchiolitis]. Nihon Kyobu Shikkan Gakkai Zasshi. 1990 Oct;28(10):1305–1313. [PubMed] [Google Scholar]
  33. Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi M., Mitsui Y., Yazaki Y., Goto K., Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988 Mar 31;332(6163):411–415. doi: 10.1038/332411a0. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES